Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology

1998 • 608 citations

The Hemostatic System as a Regulator of Angiogenesis

2000 • 322 citations

Vascular Endothelial Growth Factor (VEGF) is Released from Platelets during Blood Clotting: Implications for Measurement of Circulating VEGF Levels in Clinical Disease

1998 • 291 citations

Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.

1999 • 261 citations

Inhibition of Metastases by Anticoagulants

1999 • 238 citations

Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?

2000 • 233 citations

Serum VEGF levels in women with a benign breast tumor or breast cancer

1999 • 120 citations

Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen?

2000 • 97 citations

Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma

2000 • 87 citations

Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer

2000 • 78 citations

Soluble vascular endothelial growth factor in various blood transfusion components

1999 • 74 citations

Relationship between plasma levels of vascular endothelial growth factor and serum levels of interleukin-12 in patients with colorectal cancer.

2000 • 7 citations